Pfizer (PFE)

Pfizer said Monday it will cease research-and-development activities in Research Triangle Park and Sanford as part of a major restructuring. The announcement comes less than three weeks after the pharmaceutical giant officially brought Wyeth into the fold. The restructuring will trim the number of R&D sites at Pfizer to five main locations and nine specialized units, down from 20 sites at the close of the Wyeth deal Oct. 16.

Nov 9 · 7:24:00 PM · Source: Triangle Business Journal
Track · email · face · Twitter · digg · COMMENTS
by Larry Etter